Literature DB >> 18537924

Organ donation after physician-assisted death.

Olivier Detry, Steven Laureys, Marie-Elisabeth Faymonville, Arnaud De Roover, Jean-Paul Squifflet, Maurice Lamy, Michel Meurisse.   

Abstract

Mesh:

Year:  2008        PMID: 18537924     DOI: 10.1111/j.1432-2277.2008.00701.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


× No keyword cloud information.
  6 in total

1.  Islam and end-of-life practices in organ donation for transplantation: new questions and serious sociocultural consequences.

Authors:  Mohamed Y Rady; Joseph L Verheijde; Muna S Ali
Journal:  HEC Forum       Date:  2009-06

2.  Eligibility for organ donation following end-of-life decisions: a study performed in 43 French intensive care units.

Authors:  Olivier Lesieur; Maxime Leloup; Frédéric Gonzalez; Marie-France Mamzer
Journal:  Intensive Care Med       Date:  2014-08-05       Impact factor: 17.440

3.  Brain death, states of impaired consciousness, and physician-assisted death for end-of-life organ donation and transplantation.

Authors:  Joseph L Verheijde; Mohamed Y Rady; Joan L McGregor
Journal:  Med Health Care Philos       Date:  2009-05-13

Review 4.  Organ donation after assisted death: Is it more or less ethically-problematic than donation after circulatory death?

Authors:  Jeffrey Kirby
Journal:  Med Health Care Philos       Date:  2016-12

5.  Should we allow organ donation euthanasia? Alternatives for maximizing the number and quality of organs for transplantation.

Authors:  Dominic Wilkinson; Julian Savulescu
Journal:  Bioethics       Date:  2010-05-03       Impact factor: 1.898

6.  Eligibility of patients withheld or withdrawn from life-sustaining treatment to organ donation after circulatory arrest death: epidemiological feasibility study in a French Intensive Care Unit.

Authors:  Olivier Lesieur; Marie-France Mamzer; Maxime Leloup; Frédéric Gonzalez; Alexandre Herbland; Brigitte Hamon; Marcel-Louis Viallard; Christian Hervé
Journal:  Ann Intensive Care       Date:  2013-11-07       Impact factor: 6.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.